Skip to main content
Top
Published in: European Journal of Nutrition 4/2011

01-06-2011 | Original Contribution

Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males

Authors: T. Imatoh, S. Tanihara, M. Miyazaki, Y. Momose, Y. Uryu, H. Une

Published in: European Journal of Nutrition | Issue 4/2011

Login to get access

Abstract

Purpose

Coffee is among the most widely consumed beverages in the world. Numerous epidemiological studies have reported a significant inverse association between coffee consumption and risk of type 2 diabetes mellitus, but the underlying mechanisms are still not fully understood. Therefore, we conducted an epidemiological study to clarify the relationship between coffee consumption and adiponectin levels in Japanese males. We also evaluated whether green tea consumption affected adiponectin levels.

Methods

We carried out a cross-sectional study. The subjects were 665 male employees in Japan. Coffee consumption was assessed, using a self-administered questionnaire, as the number of times per week and cups per day respondents drank, and subjects were grouped into four levels (non, 1–5 times/week, 1–2 cups/day and ≥3 cups/day).

Results

The means of adiponectin levels were positively associated with coffee consumption. A dose–response relationship was found between coffee consumption and circulating adiponectin levels. The relationship remained significant after adjustment for potential confounding factors (P for trend <0.05). However, green tea consumption was not significantly associated with adiponectin levels (P for trend = 0.90).

Conclusions

We not only revealed that habitual coffee consumption is associated with higher adiponectin levels in Japanese males but also found a dose-dependent association between coffee consumption and adiponectin levels. Therefore, our study suggested that coffee components might play an important role in the elevation of adiponectin level.
Literature
1.
go back to reference Schaefer B (2004) Coffee consumption and type 2 diabetes mellitus. Ann Intern Med 141:323–324 Schaefer B (2004) Coffee consumption and type 2 diabetes mellitus. Ann Intern Med 141:323–324
2.
go back to reference Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46:430–435CrossRef Bravi F, Bosetti C, Tavani A, Bagnardi V, Gallus S, Negri E, Franceschi S, La Vecchia C (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46:430–435CrossRef
3.
go back to reference Lee JE, Hunter DJ, Spiegelman D et al (2007) Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer 121:2246–2253CrossRef Lee JE, Hunter DJ, Spiegelman D et al (2007) Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer 121:2246–2253CrossRef
4.
go back to reference Greenberg JA, Dunbar CC, Schnoll R, Kokolis R, Kokolis S, Kassotis J (2007) Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr 85:392–398 Greenberg JA, Dunbar CC, Schnoll R, Kokolis R, Kokolis S, Kassotis J (2007) Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr 85:392–398
5.
go back to reference Pimentel GD, Zemdegs JC, Theodoro JA, Mota JF (2009) Does long-term coffee intake reduce type 2 diabetes mellitus risk? Diabetol Metab Syndr 1:6CrossRef Pimentel GD, Zemdegs JC, Theodoro JA, Mota JF (2009) Does long-term coffee intake reduce type 2 diabetes mellitus risk? Diabetol Metab Syndr 1:6CrossRef
6.
go back to reference Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, Shimizu H (2010) Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr 103:453–459CrossRef Oba S, Nagata C, Nakamura K, Fujii K, Kawachi T, Takatsuka N, Shimizu H (2010) Consumption of coffee, green tea, oolong tea, black tea, chocolate snacks and the caffeine content in relation to risk of diabetes in Japanese men and women. Br J Nutr 103:453–459CrossRef
7.
go back to reference Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169:2053–2063CrossRef Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169:2053–2063CrossRef
8.
go back to reference van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294:97–104CrossRef van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294:97–104CrossRef
9.
go back to reference Matsuzawa Y (2005) Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 6:7–14CrossRef Matsuzawa Y (2005) Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 6:7–14CrossRef
10.
go back to reference Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935CrossRef Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935CrossRef
11.
go back to reference Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 31:504–507CrossRef Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, Mantzoros CS (2008) Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care 31:504–507CrossRef
12.
go back to reference Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, Koenig W, Sundvall J, Bidel S, Kuha S, Tuomilehto J (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91:950–957CrossRef Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, Koenig W, Sundvall J, Bidel S, Kuha S, Tuomilehto J (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91:950–957CrossRef
13.
go back to reference Ruhl CE, Everhart JE (2005) Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128:24–32CrossRef Ruhl CE, Everhart JE (2005) Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128:24–32CrossRef
14.
go back to reference Klatsky AL, Morton C, Udaltsova N, Friedman GD (2006) Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166:1190–1195CrossRef Klatsky AL, Morton C, Udaltsova N, Friedman GD (2006) Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 166:1190–1195CrossRef
15.
go back to reference Balk L, Hoekstra T, Twisk J (2009) Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol 24:203–209CrossRef Balk L, Hoekstra T, Twisk J (2009) Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol 24:203–209CrossRef
16.
go back to reference Richard D, Kefi K, Barbe U, Poli A, Bausero P, Visioli F (2009) Weight and plasma lipid control by decaffeinated green tea. Pharmacol Res 59:351–354CrossRef Richard D, Kefi K, Barbe U, Poli A, Bausero P, Visioli F (2009) Weight and plasma lipid control by decaffeinated green tea. Pharmacol Res 59:351–354CrossRef
17.
go back to reference Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292:E1378–E1387CrossRef Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292:E1378–E1387CrossRef
18.
go back to reference Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27:363–370CrossRef Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27:363–370CrossRef
19.
go back to reference Nagao T, Meguro S, Hase T, Otsuka K, Komikado M, Tokimitsu I, Yamamoto T, Yamamoto K (2009) A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity 17:310–317 Nagao T, Meguro S, Hase T, Otsuka K, Komikado M, Tokimitsu I, Yamamoto T, Yamamoto K (2009) A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity 17:310–317
20.
go back to reference Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71:356–358CrossRef Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71:356–358CrossRef
21.
go back to reference van Dieren S, Uiterwaal CSPM, van der Schouw YT, van der A DL, Boer JMA, Spijkerman A, Grobbee DE, Beulens JWJ (2009) Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 52:2561–2569CrossRef van Dieren S, Uiterwaal CSPM, van der Schouw YT, van der A DL, Boer JMA, Spijkerman A, Grobbee DE, Beulens JWJ (2009) Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 52:2561–2569CrossRef
22.
go back to reference Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 88:979–985 Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 88:979–985
23.
go back to reference Kato M, Noda M, Inoue M, Kadowaki T, Tsugane S (2009) Psychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohort. Endocr J 56:459–468CrossRef Kato M, Noda M, Inoue M, Kadowaki T, Tsugane S (2009) Psychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohort. Endocr J 56:459–468CrossRef
24.
go back to reference Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T, Sakane N (2008) The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 46:1434–1437CrossRef Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T, Sakane N (2008) The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 46:1434–1437CrossRef
25.
go back to reference Arsenault BJ, Earnest CP, Despres JP, Blair SN, Church TS (2009) Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. Eur J Clin Nutr 63:1419–1424CrossRef Arsenault BJ, Earnest CP, Despres JP, Blair SN, Church TS (2009) Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use. Eur J Clin Nutr 63:1419–1424CrossRef
26.
go back to reference van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 33:1269–1283CrossRef van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 33:1269–1283CrossRef
27.
go back to reference Hamer M, Witte DR, Mosdol A, Marmot MG, Brunner EJ (2008) Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study. Br J Nutr 100:1046–1053CrossRef Hamer M, Witte DR, Mosdol A, Marmot MG, Brunner EJ (2008) Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study. Br J Nutr 100:1046–1053CrossRef
28.
go back to reference Kagami K, Morita H, Onda K, Hirano T, Oka K (2008) Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats. J Pharm Pharmacol 60:1161–1165CrossRef Kagami K, Morita H, Onda K, Hirano T, Oka K (2008) Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats. J Pharm Pharmacol 60:1161–1165CrossRef
29.
go back to reference van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025CrossRef van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023–1025CrossRef
30.
go back to reference Greenberg JA, Axen KV, Schnoll R, Boozer CN (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes 29:1121–1129CrossRef Greenberg JA, Axen KV, Schnoll R, Boozer CN (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes 29:1121–1129CrossRef
31.
go back to reference van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478CrossRef van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478CrossRef
Metadata
Title
Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males
Authors
T. Imatoh
S. Tanihara
M. Miyazaki
Y. Momose
Y. Uryu
H. Une
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
European Journal of Nutrition / Issue 4/2011
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-010-0136-5

Other articles of this Issue 4/2011

European Journal of Nutrition 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.